Children Influenza Vaccine Industry Research Report 2025
Description
Summary
According to APO Research, the global Children Influenza Vaccine market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Children Influenza Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Children Influenza Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Children Influenza Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Children Influenza Vaccine include BCHT, CCBIO, CSL, Hulan Bio, KM Biologics, Sanofi Pasteur, Sinovac, Viatris and AstraZeneca, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Children Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Children Influenza Vaccine.
The report will help the Children Influenza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Children Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Children Influenza Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Children Influenza Vaccine Segment by Company
BCHT
CCBIO
CSL
Hulan Bio
KM Biologics
Sanofi Pasteur
Sinovac
Viatris
AstraZeneca
GSK
Jiangsu GDK
Children Influenza Vaccine Segment by Type
Nasal Spray
Injection
Children Influenza Vaccine Segment by Application
Public
Private
Children Influenza Vaccine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Children Influenza Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Children Influenza Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Children Influenza Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Children Influenza Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Children Influenza Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Children Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Children Influenza Vaccine market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Children Influenza Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Children Influenza Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Children Influenza Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Children Influenza Vaccine include BCHT, CCBIO, CSL, Hulan Bio, KM Biologics, Sanofi Pasteur, Sinovac, Viatris and AstraZeneca, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Children Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Children Influenza Vaccine.
The report will help the Children Influenza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Children Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Children Influenza Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Children Influenza Vaccine Segment by Company
BCHT
CCBIO
CSL
Hulan Bio
KM Biologics
Sanofi Pasteur
Sinovac
Viatris
AstraZeneca
GSK
Jiangsu GDK
Children Influenza Vaccine Segment by Type
Nasal Spray
Injection
Children Influenza Vaccine Segment by Application
Public
Private
Children Influenza Vaccine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Children Influenza Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Children Influenza Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Children Influenza Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Children Influenza Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Children Influenza Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Children Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Table of Contents
127 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Children Influenza Vaccine Market Size (2020-2031)
- 2.2.2 Global Children Influenza Vaccine Sales (2020-2031)
- 2.2.3 Global Children Influenza Vaccine Market Average Price (2020-2031)
- 2.3 Children Influenza Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- 2.3.2 Nasal Spray
- 2.3.3 Injection
- 2.4 Children Influenza Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.4.2 Public
- 2.4.3 Private
- 3 Market Competitive Landscape by Manufacturers
- 3.1 Global Children Influenza Vaccine Market Competitive Situation by Manufacturers (2020 Versus 2024)
- 3.2 Global Children Influenza Vaccine Sales (K Units) of Manufacturers (2020-2025)
- 3.3 Global Children Influenza Vaccine Revenue of Manufacturers (2020-2025)
- 3.4 Global Children Influenza Vaccine Average Price by Manufacturers (2020-2025)
- 3.5 Global Children Influenza Vaccine Industry Ranking, 2023 VS 2024 VS 2025
- 3.6 Global Manufacturers of Children Influenza Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Children Influenza Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Children Influenza Vaccine, Established Date
- 3.9 Global Children Influenza Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
- 4 Manufacturers Profiled
- 4.1 BCHT
- 4.1.1 BCHT Company Information
- 4.1.2 BCHT Business Overview
- 4.1.3 BCHT Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
- 4.1.4 BCHT Children Influenza Vaccine Product Portfolio
- 4.1.5 BCHT Recent Developments
- 4.2 CCBIO
- 4.2.1 CCBIO Company Information
- 4.2.2 CCBIO Business Overview
- 4.2.3 CCBIO Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
- 4.2.4 CCBIO Children Influenza Vaccine Product Portfolio
- 4.2.5 CCBIO Recent Developments
- 4.3 CSL
- 4.3.1 CSL Company Information
- 4.3.2 CSL Business Overview
- 4.3.3 CSL Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
- 4.3.4 CSL Children Influenza Vaccine Product Portfolio
- 4.3.5 CSL Recent Developments
- 4.4 Hulan Bio
- 4.4.1 Hulan Bio Company Information
- 4.4.2 Hulan Bio Business Overview
- 4.4.3 Hulan Bio Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
- 4.4.4 Hulan Bio Children Influenza Vaccine Product Portfolio
- 4.4.5 Hulan Bio Recent Developments
- 4.5 KM Biologics
- 4.5.1 KM Biologics Company Information
- 4.5.2 KM Biologics Business Overview
- 4.5.3 KM Biologics Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
- 4.5.4 KM Biologics Children Influenza Vaccine Product Portfolio
- 4.5.5 KM Biologics Recent Developments
- 4.6 Sanofi Pasteur
- 4.6.1 Sanofi Pasteur Company Information
- 4.6.2 Sanofi Pasteur Business Overview
- 4.6.3 Sanofi Pasteur Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
- 4.6.4 Sanofi Pasteur Children Influenza Vaccine Product Portfolio
- 4.6.5 Sanofi Pasteur Recent Developments
- 4.7 Sinovac
- 4.7.1 Sinovac Company Information
- 4.7.2 Sinovac Business Overview
- 4.7.3 Sinovac Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
- 4.7.4 Sinovac Children Influenza Vaccine Product Portfolio
- 4.7.5 Sinovac Recent Developments
- 4.8 Viatris
- 4.8.1 Viatris Company Information
- 4.8.2 Viatris Business Overview
- 4.8.3 Viatris Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
- 4.8.4 Viatris Children Influenza Vaccine Product Portfolio
- 4.8.5 Viatris Recent Developments
- 4.9 AstraZeneca
- 4.9.1 AstraZeneca Company Information
- 4.9.2 AstraZeneca Business Overview
- 4.9.3 AstraZeneca Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
- 4.9.4 AstraZeneca Children Influenza Vaccine Product Portfolio
- 4.9.5 AstraZeneca Recent Developments
- 4.10 GSK
- 4.10.1 GSK Company Information
- 4.10.2 GSK Business Overview
- 4.10.3 GSK Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
- 4.10.4 GSK Children Influenza Vaccine Product Portfolio
- 4.10.5 GSK Recent Developments
- 4.11 Jiangsu GDK
- 4.11.1 Jiangsu GDK Company Information
- 4.11.2 Jiangsu GDK Business Overview
- 4.11.3 Jiangsu GDK Children Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
- 4.11.4 Jiangsu GDK Children Influenza Vaccine Product Portfolio
- 4.11.5 Jiangsu GDK Recent Developments
- 5 Global Children Influenza Vaccine Market Scenario by Region
- 5.1 Global Children Influenza Vaccine Market Size by Region: 2020 VS 2024 VS 2031
- 5.2 Global Children Influenza Vaccine Sales by Region: 2020-2031
- 5.2.1 Global Children Influenza Vaccine Sales by Region: 2020-2025
- 5.2.2 Global Children Influenza Vaccine Sales by Region: 2026-2031
- 5.3 Global Children Influenza Vaccine Revenue by Region: 2020-2031
- 5.3.1 Global Children Influenza Vaccine Revenue by Region: 2020-2025
- 5.3.2 Global Children Influenza Vaccine Revenue by Region: 2026-2031
- 5.4 North America Children Influenza Vaccine Market Facts & Figures by Country
- 5.4.1 North America Children Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
- 5.4.2 North America Children Influenza Vaccine Sales by Country (2020-2031)
- 5.4.3 North America Children Influenza Vaccine Revenue by Country (2020-2031)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Children Influenza Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Children Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
- 5.5.2 Europe Children Influenza Vaccine Sales by Country (2020-2031)
- 5.5.3 Europe Children Influenza Vaccine Revenue by Country (2020-2031)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Children Influenza Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Children Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
- 5.6.2 Asia Pacific Children Influenza Vaccine Sales by Country (2020-2031)
- 5.6.3 Asia Pacific Children Influenza Vaccine Revenue by Country (2020-2031)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Children Influenza Vaccine Market Facts & Figures by Country
- 5.7.1 South America Children Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
- 5.7.2 South America Children Influenza Vaccine Sales by Country (2020-2031)
- 5.7.3 South America Children Influenza Vaccine Revenue by Country (2020-2031)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Children Influenza Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Children Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
- 5.8.2 Middle East and Africa Children Influenza Vaccine Sales by Country (2020-2031)
- 5.8.3 Middle East and Africa Children Influenza Vaccine Revenue by Country (2020-2031)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
- 6 Segment by Type
- 6.1 Global Children Influenza Vaccine Sales by Type (2020-2031)
- 6.1.1 Global Children Influenza Vaccine Sales by Type (2020-2031) & (K Units)
- 6.1.2 Global Children Influenza Vaccine Sales Market Share by Type (2020-2031)
- 6.2 Global Children Influenza Vaccine Revenue by Type (2020-2031)
- 6.2.1 Global Children Influenza Vaccine Sales by Type (2020-2031) & (US$ Million)
- 6.2.2 Global Children Influenza Vaccine Revenue Market Share by Type (2020-2031)
- 6.3 Global Children Influenza Vaccine Price by Type (2020-2031)
- 7 Segment by Application
- 7.1 Global Children Influenza Vaccine Sales by Application (2020-2031)
- 7.1.1 Global Children Influenza Vaccine Sales by Application (2020-2031) & (K Units)
- 7.1.2 Global Children Influenza Vaccine Sales Market Share by Application (2020-2031)
- 7.2 Global Children Influenza Vaccine Revenue by Application (2020-2031)
- 7.2.1 Global Children Influenza Vaccine Sales by Application (2020-2031) & (US$ Million)
- 7.2.2 Global Children Influenza Vaccine Revenue Market Share by Application (2020-2031)
- 7.3 Global Children Influenza Vaccine Price by Application (2020-2031)
- 8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Children Influenza Vaccine Value Chain Analysis
- 8.1.1 Children Influenza Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Children Influenza Vaccine Production Mode & Process
- 8.2 Children Influenza Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Children Influenza Vaccine Distributors
- 8.2.3 Children Influenza Vaccine Customers
- 9 Global Children Influenza Vaccine Analyzing Market Dynamics
- 9.1 Children Influenza Vaccine Industry Trends
- 9.2 Children Influenza Vaccine Industry Drivers
- 9.3 Children Influenza Vaccine Industry Opportunities and Challenges
- 9.4 Children Influenza Vaccine Industry Restraints
- 10 Report Conclusion
- 11 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
